Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Sanofi
Sanofi
Sanofi's last on the list to buy Bayer's glucose devices
Mass Device
Mon, 12/10/12 - 12:08 pm
Sanofi
M&A
Bayer
diabetes
Phase II Trial of Sanofi JAK2 Inhibitor in Myelofibrosis Met Primary Endpoint
Yahoo/PR Newswire
Sun, 12/9/12 - 11:32 am
Sanofi
myelofibrosis
SAR302503
7 Upcoming Biotech Catalysts For Year-End 2012 And Early 2013
Seeking Alpha
Fri, 12/7/12 - 11:45 am
Alexza
BiogenIdec
Celsion
Celgene
Sanofi
JNJ
Threshold Pharmaceuticals
Bayer diabetes unit sale unlikely - sources
Reuters
Fri, 12/7/12 - 10:37 am
Bayer
diabetes
M&A
Sanofi
Roche, Pfizer, Sanofi Plan $72.7 Million Stem-Cell Bank
Bloomberg Businessweek
Wed, 12/5/12 - 12:15 pm
Roche
Pfizer
stem cells
Sanofi
Big Pharma Sees More Approvals, Disappointing Revenues: Healthcare Business Update
Wall St. Cheat Sheet
Wed, 12/5/12 - 10:06 am
drug approvals
Pfizer
Merck
GSK
Sanofi
Roche
This Drug Helps Investors Rest Easy
Motley Fool
Sun, 12/2/12 - 12:03 pm
suvorexant
Merck
insomnia
hypnotics
Sanofi
Ambien
Amarin Is Really Good At Delays, Drug Launches Not So Much
TheStreet.com
Thu, 11/29/12 - 10:42 am
Amarin
Vascepa
drug launches
Celgene
Sanofi
10 top drug launch disasters
Fierce Pharma
Wed, 11/28/12 - 11:13 am
drug launches
Rare Disease Therapeutics
Anascorp
AstraZeneca
Brilinta
Somaxon
Silenor
Sanofi
Multaq
Savient
Krystexxa
XenoPort
Horizant
Human Genome Sciences
Benlysta
Zaltrap
Dendreon
Provenge
KV Pharmaceutical
Makena
Investing in a better flu shot
Markewatch
Tue, 11/27/12 - 10:29 am
vaccines
Flu
GSK
AstraZeneca
Sanofi
This Week in Biotech
Motley Fool
Sun, 11/25/12 - 11:15 am
Arena
Vivus
Regeneron
Sanofi
MAP Pharmaceuticals
Allergan
Celgene, Sanofi Executives Charged With Insider Trading
Wed, 11/21/12 - 02:17 pm
Celgene
Sanofi
Management
legal
insider trading
stock
Overnight success proves elusive for oral MS drugs
Fierce Pharma
Tue, 11/20/12 - 01:25 pm
multiple sclerosis
MS
Novartis
Gilenya
Sanofi
Aubagio
Novo Nordisk A/S: Catching The Increasing Diabetes Trend
Seeking Alpha
Tue, 11/20/12 - 11:27 am
diabetes
Novo Nordisk
Bristol-Myers Squibb
Eli Lilly
Sanofi
This Top-Dollar Drug Hits the Discount Rack
Motley Fool
Sat, 11/17/12 - 01:27 pm
Sanofi
Dendreon
Regeneron
Zaltrap
Sanofi Wins EU Backing for New Drugs Against Diabetes and Cancer
Bloomberg
Fri, 11/16/12 - 10:43 am
Sanofi
Europe
diabetes
Zaltrap
colorectal cancer
Lyxumia
Teva Is Still Healthier Than Its Big Pharma Peers
Seeking Alpha
Thu, 11/15/12 - 10:47 am
Teva
AstraZeneca
Bristol-Myers Squibb
GSK
JNJ
Merck
Novo Nordisk
Novartis
Pfizer
Sanofi
'Super' Novavax: Company Outshines Stars Of Pandemic Influenza Vaccine Production
Seeking Alpha
Wed, 11/14/12 - 11:13 am
Novavax
Flu
vaccines
GSK
Merck
Novartis
Sanofi
Prostate Cancer Market Takes Shape - Part 1: Dendreon And Medivation
Seeking Alpha
Wed, 11/14/12 - 10:33 am
prostate cancer
Medivation
Dendreon
Provenge
JNJ
Sanofi
Sanofi's Menactra Data Published
Yahoo/Zacks
Tue, 11/13/12 - 05:35 pm
Sanofi
Menactra
vaccines
meningococcal disease
Pages
« first
‹ previous
…
97
98
99
100
101
102
103
104
105
…
next ›
last »